# Zhaokai Zhou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zhaokai-zhou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,489 |
| Field | Ferroptosis and cancer prognosis |
| h-index | 20 |
| i10-index | 38 |
| Last Known Institution | Central South University |
| OpenAlex ID | https://openalex.org/A5051283231 |
| ORCID iD | 0000-0001-6628-3750 |
| Works | 95 |

## Researcher papers

- [Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy](https://scholariq.org/papers/immunosuppression-in-tumor-immune-microenvironment-and-its-optimization-from-car/)
- [Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis](https://scholariq.org/papers/multifaceted-role-of-redox-pattern-in-the-tumor-immune-microenvironment/)
- [Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance](https://scholariq.org/papers/ferroptosis-and-emt-key-targets-for-combating-cancer-progression-and-therapy/)
- [THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer](https://scholariq.org/papers/thbs2-cancer-associated-fibroblasts-promote-emt-leading-to-oxaliplatin/)
- [Biological and pharmacological roles of m6A modifications in cancer drug resistance](https://scholariq.org/papers/biological-and-pharmacological-roles-of-m6a-modifications-in-cancer-drug/)
- [Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma](https://scholariq.org/papers/mitochondrial-pathway-signature-mitops-predicts-immunotherapy-response-and/)
- [Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy](https://scholariq.org/papers/metabolic-checkpoints-in-immune-cell-reprogramming-rewiring-immunometabolism-for/)
- [Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond](https://scholariq.org/papers/deciphering-the-tumor-immune-microenvironment-from-a-multidimensional-omics/)
- [Engineering neoantigen vaccines to improve cancer personalized immunotherapy](https://scholariq.org/papers/engineering-neoantigen-vaccines-to-improve-cancer-personalized-immunotherapy/)
- [Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes](https://scholariq.org/papers/smooth-muscle-cell-fate-decisions-decipher-a-high-resolution-heterogeneity/)
- [Glucagon-like peptide-1 receptor agonists and sarcopenia-related markers in diabetes: A systematic review and meta-analysis](https://scholariq.org/papers/glucagon-like-peptide-1-receptor-agonists-and-sarcopenia-related-markers-in/)

## Researcher topics

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)

## Researcher university

- [Central South University](https://scholariq.org/institutions/central-south-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.